Radiofrequency ablation with or without capecitabine maintenance therapy for lung oligometastases from colorectal cancer

doi:10.3748/wjg.v31.i35.110152

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 35

This Article

(40)

(75)

(0)

(12)

(1085)

(2)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 21, 2025; 31(35): 110152
Published online Sep 21, 2025. doi: 10.3748/wjg.v31.i35.110152

Full Size Figure Download Figure

Figure 1 Flowchart of patient inclusion and exclusion. CRC: Colorectal cancer; RFA: Radiofrequency ablation; Combined: Radiofrequency ablation plus capecitabine; Only RFA: Radiofrequency ablation alone.

Citation: Li KN, Ying LL, Du N, Wang Y, Huang HZ, Wang YH, Xu LC, Zhao Q, Song G, Hu YB, Li WT, Yan Y, Chen C, He XH. Radiofrequency ablation with or without capecitabine maintenance therapy for lung oligometastases from colorectal cancer. World J Gastroenterol 2025; 31(35): 110152
URL: https://www.wjgnet.com/1007-9327/full/v31/i35/110152.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i35.110152

Li KN, Ying LL, Du N, Wang Y, Huang HZ, Wang YH, Xu LC, Zhao Q, Song G, Hu YB, Li WT, Yan Y, Chen C, He XH. Radiofrequency ablation with or without capecitabine maintenance therapy for lung oligometastases from colorectal cancer. World J Gastroenterol 2025; 31(35): 110152 [PMID: 41024768 DOI: 10.3748/wjg.v31.i35.110152]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.